1. Home
  2. BOLD vs STAI Comparison

BOLD vs STAI Comparison

Compare BOLD & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • STAI
  • Stock Information
  • Founded
  • BOLD 2018
  • STAI 2011
  • Country
  • BOLD United States
  • STAI United States
  • Employees
  • BOLD N/A
  • STAI N/A
  • Industry
  • BOLD
  • STAI
  • Sector
  • BOLD
  • STAI
  • Exchange
  • BOLD Nasdaq
  • STAI Nasdaq
  • Market Cap
  • BOLD 24.4M
  • STAI 24.6M
  • IPO Year
  • BOLD 2024
  • STAI N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • STAI $0.43
  • Analyst Decision
  • BOLD Buy
  • STAI
  • Analyst Count
  • BOLD 4
  • STAI 0
  • Target Price
  • BOLD $4.00
  • STAI N/A
  • AVG Volume (30 Days)
  • BOLD 77.7K
  • STAI 6.1M
  • Earning Date
  • BOLD 11-06-2025
  • STAI 10-26-2025
  • Dividend Yield
  • BOLD N/A
  • STAI N/A
  • EPS Growth
  • BOLD N/A
  • STAI N/A
  • EPS
  • BOLD N/A
  • STAI N/A
  • Revenue
  • BOLD N/A
  • STAI $907,637.00
  • Revenue This Year
  • BOLD N/A
  • STAI N/A
  • Revenue Next Year
  • BOLD N/A
  • STAI N/A
  • P/E Ratio
  • BOLD N/A
  • STAI N/A
  • Revenue Growth
  • BOLD N/A
  • STAI N/A
  • 52 Week Low
  • BOLD $1.00
  • STAI $0.35
  • 52 Week High
  • BOLD $4.72
  • STAI $9.07
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 49.88
  • STAI 44.98
  • Support Level
  • BOLD $1.13
  • STAI $0.35
  • Resistance Level
  • BOLD $1.16
  • STAI $0.45
  • Average True Range (ATR)
  • BOLD 0.04
  • STAI 0.04
  • MACD
  • BOLD 0.00
  • STAI 0.01
  • Stochastic Oscillator
  • BOLD 55.56
  • STAI 57.69

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About STAI ScanTech AI Systems Inc. Common stock

ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.

Share on Social Networks: